Physician profile
Kenneth B Dodge
NPI 1417951302
$5,547.67
in general payments reported to CMS, 2019-2025
41 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,676 · 2020: $968 · 2021: $915 · 2022: $468 · 2023: $574 · 2024: $672 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496 · Education: $25.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.37 |
| Education | $25.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,183.96 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $813.41 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $540.55 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $339.97 | 2021-2024 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $301.88 | 2019-2021 | |
| Glaxosmithkline, LLC. | $211.49 | 2019-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $197.52 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $182.67 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $172.22 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $139.89 | 2019-2020 | |
| Astellas Pharma US INC | $133.32 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $132.47 | 2019-2023 | |
| Pfizer INC. | $131.42 | 2019-2024 | |
| Xeris Pharmaceuticals, INC. | $129.89 | 2023-2025 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.44 | 2019-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Dodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.